Purdue Pharma: $7.4 Billion Plan Goes Effective, Knoa Pharma Begins Operations
Purdue Pharma's chapter 11 plan went effective April 1, 2026, completing a six-year mass-tort restructuring. The $7.4 billion Sackler settlement and $8.344 billion DOJ resolution are now operative. Knoa Pharma LLC began operations May 1 as the public-benefit pharmaceutical successor.
FreefallHealthcare & life sciences